Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Marc Hansen is listed as Founder and CEO,Magellan Bioanalytics Inc at Magellan Bioanalytics, Inc., based in Provo, Utah, United States. AeroLeads shows a matched LinkedIn profile for Marc Hansen.
Marc Hansen previously worked as Founder and CEO at Magellan Bioanalytics, Inc. and Entrepreneur- and Scientist-in-residence at Neurostar Investment Fund. Marc Hansen holds Phd, Cancer Biology from Stanford University School Of Medicine.
This section adds company-level context without repeating Marc Hansen's masked contact details.
Review company-level records connected to Marc Hansen before choosing the right outreach path.
My strength is in turning life sciences technology-based idea into new biotech ventures. I've founded two companies, one that developed a new oncology small molecule therapeutic and another that built software that overcomes the data limitations in mass spectrometry-based -omics that allows for true integration with sequencing-based -omics.As part of my academic research over a 15 academic career, I led a research group using methods from my cell biology training, and expanded my research toolbox with direct research experience in bioinformatics, computational biology, data science, proteomics, molecular modeling, chemical genetics, and medicinal chemistry. Along the way I co-led a team to build a two-photon microscope.As part of my scientific experience in biotech I have developed small molecule therapeutics programs from concept through preclinical proof-of-concept and clinical candidate selection and then into IND readiness. I also have experience with early clinical trial design, IND preparation, and successful FDA approval for clinical studies. In the software space, I led a small team to develop novel computational tools to rapidly extract information from very large mass spec-based -omics datasets and apply machine learning methods to this type of data. These computational tools were recently released as a commercial scientific software product and are being used by biotech companies to define biomarker profiles associated with clinical outcomes in a clinical trial setting.I have experience with patent design and prosecution, both in the small molecule therapeutics and computational experience. For the former, I led the prosecution strategy that resulted in patents being granted across multiple international jurisdictions.My business experience includes company leadership at the C and VP level. I have raised capital, negotiated tech transfer licenses, negotiated license and acquisition term sheets, developed and overseen partnerships and collaborations, directed research programs with both internal teams and CROs. My experience is with small, early stage companies that require fluidity in role and understanding how to work with a mix of complexity and uncertainty.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Magellan Bioanalytics provides computational tools to analyze biomolecular datasets at massive data scales, focusing on data from mass spec (proteomics, metabolomics, lipidomics) but also integrating this type of data with other data types like DNA sequencing.
I assisted in identifying and screening life sciences investment opportunities, negotiated terms for those opportunities, and assisted in the active management/operation of portfolio companies.
Ran preclinical and nonclinical drug discovery operations in both chemistry and biology, including identifying new drug programs, advancing existing preclinical drug programs, and supporting a phase II clinical program. I also helped identify BDNL opportunities and strategic partnerships/collaborations.
Salt Lake City, UT
Privately funded, we are readying an experimental oncology drug for clinical trials. This therapeutic was developed from concept to clinical candidate under my leadership.
In my academic research I use cell models to study cellular and molecular events underlying detachment of cells from epithelial tissues, a critical process in development and cancer metastasis. We use a wide variety of approaches, including cell imaging, bioinformatics, computational and mathematical modeling, and chemical genetics.Another interest is in.
This is a high level consulting role designed to guide preclinical small molecule drug development programs through preclinical development as antiviral therapeutics. This includes evaluating natural products as potential therapeutics, directing optimization of lead compounds, and overseeing a preclinical research effort designed to nominate clinical.
Salt Lake City, UT
Mentoring life sciences startups that received TCIP awards from the Utah Governor's office as part of their summer accelerator experience with Boom Startup.
Salt Lake City, UT
Advised TetraGene in how to position itself to raise money and develop partnerships to develop novel therapeutics based on its platform technology.
London, UK
Mathematical and computational modeling of cell biological processes.
Cell biology of adhesion and migration.
Quick answers generated from the profile data available on this page.
Marc Hansen works for Magellan Bioanalytics, Inc..
Marc Hansen is listed as Founder and CEO,Magellan Bioanalytics Inc at Magellan Bioanalytics, Inc..
Marc Hansen is based in Provo, Utah, United States while working with Magellan Bioanalytics, Inc..
Marc Hansen has worked for Magellan Bioanalytics, Inc., Neurostar Investment Fund, Xenter Therapeutics, Frost Biologic, and Brigham Young University.
You can use AeroLeads to view verified contact signals for Marc Hansen at Magellan Bioanalytics, Inc., including work email, phone, and LinkedIn data when available.
Marc Hansen holds Phd, Cancer Biology from Stanford University School Of Medicine.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Marc Hansen you were looking for.
View similar profiles
